Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Preliminary Evidence for the Cognitive Model of Auditory Verbal Hallucinations in Youth With Borderline Personality Disorder.

Cavelti M, Thompson K, Hulbert C, Betts J, Jackson H, Francey S, Chanen A.

Front Psychiatry. 2019 May 16;10:292. doi: 10.3389/fpsyt.2019.00292. eCollection 2019.

2.

Aripiprazole compared with placebo for auditory verbal hallucinations in youth with borderline personality disorder: Protocol for the VERBATIM randomized controlled trial.

Chanen AM, Betts J, Jackson H, McGorry P, Nelson B, Cotton SM, Bartholomeusz C, Jovev M, Ratheesh A, Davey C, Pantelis C, McCutcheon L, Francey S, Bhaduri A, Lowe D, Rayner V, Thompson K.

Early Interv Psychiatry. 2019 Jan 28. doi: 10.1111/eip.12774. [Epub ahead of print]

PMID:
30689305
3.

Exploratory comparison of auditory verbal hallucinations and other psychotic symptoms among youth with borderline personality disorder or schizophrenia spectrum disorder.

Cavelti M, Thompson KN, Hulbert C, Betts J, Jackson H, Francey S, Homan P, Chanen AM.

Early Interv Psychiatry. 2019 Oct;13(5):1252-1262. doi: 10.1111/eip.12763. Epub 2018 Nov 28.

PMID:
30485670
4.

Staged treatment and acceptability guidelines in early psychosis study (STAGES): A randomized placebo controlled trial of intensive psychosocial treatment plus or minus antipsychotic medication for first-episode psychosis with low-risk of self-harm or aggression. Study protocol and baseline characteristics of participants.

O'Donoghue B, Francey SM, Nelson B, Ratheesh A, Allott K, Graham J, Baldwin L, Alvarez-Jimenez M, Thompson A, Fornito A, Polari A, Berk M, Macneil C, Crisp K, Pantelis C, Yuen HP, Harrigan S, McGorry P.

Early Interv Psychiatry. 2019 Aug;13(4):953-960. doi: 10.1111/eip.12716. Epub 2018 Jul 19.

PMID:
30024100
5.

Early psychosis workforce development: Core competencies for mental health professionals working in the early psychosis field.

Osman H, Jorm AF, Killackey E, Francey S, Mulcahy D.

Early Interv Psychiatry. 2019 Apr;13(2):217-223. doi: 10.1111/eip.12465. Epub 2017 Aug 9.

PMID:
28792114
6.

Does co-occurring borderline personality disorder influence acute phase treatment for first-episode psychosis?

Francey SM, Jovev M, Phassouliotis C, Cotton SM, Chanen AM.

Early Interv Psychiatry. 2018 Dec;12(6):1166-1172. doi: 10.1111/eip.12435. Epub 2017 May 18.

PMID:
28516734
7.

Predictors of favourable outcome in young people with a first episode psychosis without antipsychotic medication.

Conus P, Cotton SM, Francey SM, O'Donoghue B, Schimmelmann BG, McGorry PD, Lambert M.

Schizophr Res. 2017 Jul;185:130-136. doi: 10.1016/j.schres.2016.12.029. Epub 2017 Jan 6.

PMID:
28065484
8.

Factors influencing engagement with case managers: Perspectives of young people with a diagnosis of first episode psychosis.

Tindall R, Francey S, Hamilton B.

Int J Ment Health Nurs. 2015 Aug;24(4):295-303. doi: 10.1111/inm.12133. Epub 2015 May 14.

PMID:
25976922
9.

Suicidal behaviours during treatment for first-episode psychosis: towards a comprehensive approach to service-based prevention.

Fedyszyn IE, Robinson J, Harris MG, Paxton SJ, Francey S, Edwards J.

Early Interv Psychiatry. 2014 Nov;8(4):387-95. doi: 10.1111/eip.12084. Epub 2013 Aug 22.

PMID:
23964750
10.

Long-term follow-up of a group at ultra high risk ("prodromal") for psychosis: the PACE 400 study.

Nelson B, Yuen HP, Wood SJ, Lin A, Spiliotacopoulos D, Bruxner A, Broussard C, Simmons M, Foley DL, Brewer WJ, Francey SM, Amminger GP, Thompson A, McGorry PD, Yung AR.

JAMA Psychiatry. 2013 Aug;70(8):793-802. doi: 10.1001/jamapsychiatry.2013.1270. Erratum in: JAMA Psychiatry. 2013 Oct;70(10):1008.

PMID:
23739772
11.

Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: twelve-month outcome.

McGorry PD, Nelson B, Phillips LJ, Yuen HP, Francey SM, Thampi A, Berger GE, Amminger GP, Simmons MB, Kelly D, Dip G, Thompson AD, Yung AR.

J Clin Psychiatry. 2013 Apr;74(4):349-56. doi: 10.4088/JCP.12m07785. Epub 2012 Nov 27.

PMID:
23218022
12.

Embracing patient choice.

Francey SM, McGorry P, Nelson B.

Br J Psychiatry. 2012 Dec;201(6):493-4. doi: 10.1192/bjp.201.6.493a. No abstract available.

PMID:
23209095
13.

Predictors of suicide-related behaviors during treatment following a first episode of psychosis: the contribution of baseline, past, and recent factors.

Fedyszyn IE, Robinson J, Harris MG, Paxton SJ, Francey S.

Schizophr Res. 2012 Sep;140(1-3):17-24. doi: 10.1016/j.schres.2012.06.022. Epub 2012 Jul 10.

PMID:
22784686
14.

Comparison of experiences of stress and coping between young people at risk of psychosis and a non-clinical cohort.

Phillips LJ, Edwards J, McMurray N, Francey S.

Behav Cogn Psychother. 2012 Jan;40(1):69-88. doi: 10.1017/S1352465811000397. Epub 2011 Jul 5.

PMID:
21729339
15.

Letter to the editor. The need for drug-naive research in first-episode psychosis: a response to Moncrieff & Leo (2010).

Nelson B, Yung AR, McGorry PD, Spiliotacopoulos D, Francey SM.

Psychol Med. 2011 May;41(5):1117-8. doi: 10.1017/S0033291711000262. Epub 2011 Mar 4. No abstract available.

PMID:
21375800
16.

Randomized controlled trial of interventions for young people at ultra high risk for psychosis: 6-month analysis.

Yung AR, Phillips LJ, Nelson B, Francey SM, PanYuen H, Simmons MB, Ross ML, Kelly D, Baker K, Amminger GP, Berger G, Thompson AD, Thampi A, McGorry PD.

J Clin Psychiatry. 2011 Apr;72(4):430-40. doi: 10.4088/JCP.08m04979ora. Epub 2010 Oct 19.

PMID:
21034687
17.

Study protocol: The development of a pilot study employing a randomised controlled design to investigate the feasibility and effects of a peer support program following discharge from a specialist first-episode psychosis treatment centre.

Robinson J, Bruxner A, Harrigan S, Bendall S, Killackey E, Tonin V, Monson K, Thurley M, Francey S, Yung AR.

BMC Psychiatry. 2010 May 25;10:37. doi: 10.1186/1471-244X-10-37.

18.

Who needs antipsychotic medication in the earliest stages of psychosis? A reconsideration of benefits, risks, neurobiology and ethics in the era of early intervention.

Francey SM, Nelson B, Thompson A, Parker AG, Kerr M, Macneil C, Fraser R, Hughes F, Crisp K, Harrigan S, Wood SJ, Berk M, McGorry PD.

Schizophr Res. 2010 Jun;119(1-3):1-10. doi: 10.1016/j.schres.2010.02.1071. Epub 2010 Mar 26. Review.

PMID:
20347270
19.

Experience of trauma and conversion to psychosis in an ultra-high-risk (prodromal) group.

Bechdolf A, Thompson A, Nelson B, Cotton S, Simmons MB, Amminger GP, Leicester S, Francey SM, McNab C, Krstev H, Sidis A, McGorry PD, Yung AR.

Acta Psychiatr Scand. 2010 May;121(5):377-84. doi: 10.1111/j.1600-0447.2010.01542.x. Epub 2010 Feb 25.

PMID:
20199494
20.

Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: study design and baseline characteristics.

Phillips LJ, Nelson B, Yuen HP, Francey SM, Simmons M, Stanford C, Ross M, Kelly D, Baker K, Conus P, Amminger P, Trumpler F, Yun Y, Lim M, McNab C, Yung AR, McGorry PD.

Aust N Z J Psychiatry. 2009 Sep;43(9):818-29. doi: 10.1080/00048670903107625.

PMID:
19670055
21.

Intervention in individuals at ultra-high risk for psychosis: a review and future directions.

McGorry PD, Nelson B, Amminger GP, Bechdolf A, Francey SM, Berger G, Riecher-Rössler A, Klosterkötter J, Ruhrmann S, Schultze-Lutter F, Nordentoft M, Hickie I, McGuire P, Berk M, Chen EY, Keshavan MS, Yung AR.

J Clin Psychiatry. 2009 Sep;70(9):1206-12. doi: 10.4088/JCP.08r04472. Epub 2009 Jun 30. Review.

PMID:
19573499
22.

Does disturbance of self underlie social cognition deficits in schizophrenia and other psychotic disorders?

Nelson B, Sass LA, Thompson A, Yung AR, Francey SM, Amminger GP, McGorry PD.

Early Interv Psychiatry. 2009 May;3(2):83-93. doi: 10.1111/j.1751-7893.2009.00112.x. Review.

PMID:
21352181
23.

Strategies used by psychotic individuals to cope with life stress and symptoms of illness: a systematic review.

Phillips LJ, Francey SM, Edwards J, McMurray N.

Anxiety Stress Coping. 2009 Jul;22(4):371-410. doi: 10.1080/10615800902811065. Review.

PMID:
19333796
24.

Development, validation and transfer into a factory environment of a liquid chromatography tandem mass spectrometry assay for the highly neurotoxic impurity FMTP (4-(4-fluorophenyl)-1-methyl-1,2,3,6-tetrahydropyridine) in paroxetine active pharmaceutical ingredient (API).

Borman PJ, Chatfield MJ, Crowley EL, Eckers C, Elder DP, Francey SW, Laures AM, Wolff JC.

J Pharm Biomed Anal. 2008 Dec 1;48(4):1082-9. doi: 10.1016/j.jpba.2008.08.026. Epub 2008 Aug 30.

PMID:
18835674
25.

Identifying the ultra-high risk (prodromal) population: evaluation of training workshops with mental health services.

Nelson B, Simmons MB, Yung AR, Buckby JA, O'Dwyer L, Francey SM, Leicester S, Bapat S, McGorry PD.

Aust N Z J Psychiatry. 2008 Mar;42(3):236-43. doi: 10.1080/00048670701827630.

PMID:
18247199
26.

Cognitive decline following psychosis onset: data from the PACE clinic.

Wood SJ, Brewer WJ, Koutsouradis P, Phillips LJ, Francey SM, Proffitt TM, Yung AR, Jackson HJ, McGorry PD, Pantelis C.

Br J Psychiatry Suppl. 2007 Dec;51:s52-7. doi: 10.1192/bjp.191.51.s52.

PMID:
18055938
27.

PACE: a specialised service for young people at risk of psychotic disorders.

Yung AR, McGorry PD, Francey SM, Nelson B, Baker K, Phillips LJ, Berger G, Amminger GP.

Med J Aust. 2007 Oct 1;187(7 Suppl):S43-6.

PMID:
17908025
28.

Medium term follow-up of a randomized controlled trial of interventions for young people at ultra high risk of psychosis.

Phillips LJ, McGorry PD, Yuen HP, Ward J, Donovan K, Kelly D, Francey SM, Yung AR.

Schizophr Res. 2007 Nov;96(1-3):25-33. Epub 2007 Jul 3.

PMID:
17611080
29.

Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk?

Yung AR, Yuen HP, Berger G, Francey S, Hung TC, Nelson B, Phillips L, McGorry P.

Schizophr Bull. 2007 May;33(3):673-81. Epub 2007 Apr 2.

30.

Antibodies to infectious agents in individuals at ultra-high risk for psychosis.

Amminger GP, McGorry PD, Berger GE, Wade D, Yung AR, Phillips LJ, Harrigan SM, Francey SM, Yolken RH.

Biol Psychiatry. 2007 May 15;61(10):1215-7. Epub 2007 Jan 3.

PMID:
17207471
31.

Stress and psychosis: towards the development of new models of investigation.

Phillips LJ, Francey SM, Edwards J, McMurray N.

Clin Psychol Rev. 2007 Apr;27(3):307-17. Epub 2006 Dec 13. Review.

PMID:
17169470
32.

A blinded, placebo-controlled randomized trial of low-dose risperidone, intensive psychological treatment and befriending in young people at risk of psychotic disorder: baseline characteristics of the sample.

McGorry P, Yung A, Francey S, Phillips L, Nelson B.

Acta Neuropsychiatr. 2006 Dec;18(6):261. doi: 10.1017/S0924270800030556. No abstract available.

PMID:
27397212
33.

Generalized and specific cognitive performance in clinical high-risk cohorts: a review highlighting potential vulnerability markers for psychosis.

Brewer WJ, Wood SJ, Phillips LJ, Francey SM, Pantelis C, Yung AR, Cornblatt B, McGorry PD.

Schizophr Bull. 2006 Jul;32(3):538-55. Epub 2006 Jun 16. Review.

34.

Early-onset of symptoms predicts conversion to non-affective psychosis in ultra-high risk individuals.

Amminger GP, Leicester S, Yung AR, Phillips LJ, Berger GE, Francey SM, Yuen HP, McGorry PD.

Schizophr Res. 2006 May;84(1):67-76. Epub 2006 May 4.

PMID:
16677803
35.

Recent approaches to psychological interventions for people at risk of psychosis.

Bechdolf A, Phillips LJ, Francey SM, Leicester S, Morrison AP, Veith V, Klosterkötter J, McGorry PD.

Eur Arch Psychiatry Clin Neurosci. 2006 Apr;256(3):159-73.

PMID:
16639521
36.

Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States.

Yung AR, Yuen HP, McGorry PD, Phillips LJ, Kelly D, Dell'Olio M, Francey SM, Cosgrave EM, Killackey E, Stanford C, Godfrey K, Buckby J.

Aust N Z J Psychiatry. 2005 Nov-Dec;39(11-12):964-71.

PMID:
16343296
37.

A controlled trial of cognitively oriented psychotherapy for early psychosis (COPE) with four-year follow-up readmission data.

Jackson H, McGorry P, Edwards J, Hulbert C, Henry L, Harrigan S, Dudgeon P, Francey S, Maude D, Cocks J, Killackey E, Power P.

Psychol Med. 2005 Sep;35(9):1295-306.

PMID:
16168152
38.

Sustained attention in young people at high risk of psychosis does not predict transition to psychosis.

Francey SM, Jackson HJ, Phillips LJ, Wood SJ, Yung AR, McGorry PD.

Schizophr Res. 2005 Nov 1;79(1):127-36.

PMID:
16107309
39.

The PACE Clinic: identification and management of young people at "ultra" high risk of psychosis.

Phillips LJ, Leicester SB, O'Dwyer LE, Francey SM, Koutsogiannis J, Abdel-Baki A, Kelly D, Jones S, Vay C, Yung AR, McGorry PD.

J Psychiatr Pract. 2002 Sep;8(5):255-69.

PMID:
15985888
40.

Obstetric complications and transition to psychosis in an "ultra" high risk sample.

Yun Y, Phillips LJ, Cotton S, Yung AR, Francey SM, Yuen HP, McGorry PD.

Aust N Z J Psychiatry. 2005 Jun;39(6):460-6.

PMID:
15943647
41.

Memory impairments identified in people at ultra-high risk for psychosis who later develop first-episode psychosis.

Brewer WJ, Francey SM, Wood SJ, Jackson HJ, Pantelis C, Phillips LJ, Yung AR, Anderson VA, McGorry PD.

Am J Psychiatry. 2005 Jan;162(1):71-8.

PMID:
15625204
42.

Impairment of olfactory identification ability in individuals at ultra-high risk for psychosis who later develop schizophrenia.

Brewer WJ, Wood SJ, McGorry PD, Francey SM, Phillips LJ, Yung AR, Anderson V, Copolov DL, Singh B, Velakoulis D, Pantelis C.

Am J Psychiatry. 2003 Oct;160(10):1790-4.

PMID:
14514492
43.

Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group.

Yung AR, Phillips LJ, Yuen HP, Francey SM, McFarlane CA, Hallgren M, McGorry PD.

Schizophr Res. 2003 Mar 1;60(1):21-32.

PMID:
12505135
44.

Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms.

McGorry PD, Yung AR, Phillips LJ, Yuen HP, Francey S, Cosgrave EM, Germano D, Bravin J, McDonald T, Blair A, Adlard S, Jackson H.

Arch Gen Psychiatry. 2002 Oct;59(10):921-8.

PMID:
12365879
45.

Shedding of Escherichia coli O157:H7 in dairy cattle housed in a confined environment following waterborne inoculation.

Shere JA, Kaspar CW, Bartlett KJ, Linden SE, Norell B, Francey S, Schaefer DM.

Appl Environ Microbiol. 2002 Apr;68(4):1947-54.

46.

Cognitively oriented psychotherapy for early psychosis (COPE): a 1-year follow-up.

Jackson H, McGorry P, Henry L, Edwards J, Hulbert C, Harrigan S, Dudgeon P, Francey S, Maude D, Cocks J, Power P.

Br J Clin Psychol. 2001 Mar;40(1):57-70.

PMID:
11317949
47.

Group programmes for recovery from early psychosis.

Albiston DJ, Francey SM, Harrigan SM.

Br J Psychiatry Suppl. 1998;172(33):117-21.

PMID:
9764137
48.

Cognitively-oriented psychotherapy for early psychosis (COPE). Preliminary results.

Jackson H, McGorry P, Edwards J, Hulbert C, Henry L, Francey S, Maude D, Cocks J, Power P, Harrigan S, Dudgeon P.

Br J Psychiatry Suppl. 1998;172(33):93-100.

PMID:
9764134
49.

Prediction of psychosis. A step towards indicated prevention of schizophrenia.

Yung AR, Phillips LJ, McGorry PD, McFarlane CA, Francey S, Harrigan S, Patton GC, Jackson HJ.

Br J Psychiatry Suppl. 1998;172(33):14-20.

PMID:
9764121

Supplemental Content

Loading ...
Support Center